Charles Conway, MD
Psychiatry · Saint Louis, MONPI 1497771356
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Livanova USA, Inc. accounts for 88.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $7,985 and has fallen 99.7% since, to $25 in 2025. Among psychiatry clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $370.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$16K
- Sage Therapeutics, LLC$2K
- Abbott$505
- Sunovion Pharmaceuticals Inc.$23
- BTG International Inc.$14
Across 98 payments — averaging $38,710 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Livanova USA, Inc.$3.7M
- Abbott$142K
What the payments were for
- Consulting fees$1,6439%
- Speaking & faculty fees$9,99855%
- Travel & lodging$3,43319%
- Food & beverage$3,04317%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 40 | $15,946 |
| Sage Therapeutics, LLC | 2 | $1,643 |
| Abbott | 4 | $505 |
| Sunovion Pharmaceuticals Inc. | 1 | $23 |
| BTG International Inc. | 2 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy Symmetry Model 8103 Generator$13,348
- VNS Therapy$1,275
- INFINITY$430
- VNS - Symmetry$262
How this compares
$18,131 in reported general payments places this provider in the 95th percentile of 680 psychiatry providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Wellbutrin XlBupropion Hcl | 12 | $81,537 |
| Ziprasidone Hcl | 26 | $5,029 |
| Clozapine | 47 | $2,597 |
| Olanzapine OdtOlanzapine | 24 | $1,775 |
| Quetiapine Fumarate | 18 | $1,220 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $694 |
| Lithium Carbonate | 17 | $430 |
| Trazodone Hcl | 20 | $411 |
| Bupropion Hcl SrBupropion Hcl | 16 | $325 |
| Lamotrigine | 17 | $309 |
| Clonazepam | 12 | $140 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Saint Louis
- Vadim BaramSaint Louis$1.9M
- Adam SkySaint Louis$1.1M
- Mohd MalikSaint Louis$956K
- George GrossbergSaint Louis$501K
- Christopher LoyndSaint Louis$265K
- Devnandini RastogiSaint Louis$261K
- Michael StotlerSaint Louis$250K
- James ChoSaint Louis$118K
- Steven HarveySaint Louis$90K
- Kevin BlackSaint Louis$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.